In a significant advancement for infant health, newborns across the country will soon have access to preventive treatment against the Respiratory Syncytial Virus (RSV), effective September 10. RSV is a common respiratory virus that typically causes mild, cold-like symptoms but can lead to severe respiratory issues in infants, particularly those born prematurely or with underlying…